AKRO - Akero Therapeutics EPS misses by $0.14 November, 12 2019 07:19 AM Akero Therapeutics Inc. Akero Therapeutics (NASDAQ:AKRO): Q3 GAAP EPS of -$0.56 misses by $0.14.Cash and cash equivalents of $147.8MPress ReleaseMore news on: Akero Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,